
|Articles|April 17, 2014
- Melanoma (Issue 2)
- Volume 2
- Issue 1
Sequencing Strategies in Treating Patients With Melanoma
Author(s)Michael A. Postow, MD
Michael A. Postow, MD, attending physician, Melanoma and Immunotherapeutics Service, Memorial Sloan Kettering Cancer Center, discusses sequencing strategies in treating patients with melanoma.
Advertisement
Michael A. Postow, MD, attending physician, Melanoma and Immunotherapeutics Service, Memorial Sloan Kettering Cancer Center, discusses sequencing strategies in treating patients with melanoma.
Learn more about sequencing strategies in melanoma > >
Articles in this issue
over 11 years ago
Research Into Newer Agents Under Way for NRAS Melanomaover 11 years ago
New Crop of Combination Strategies Growing for Melanomaover 11 years ago
An Overview of Immune Checkpoint Blockadeover 11 years ago
In Practice: Combination Therapies in Metastatic Melanomaover 11 years ago
New and Emerging Therapies for Metastatic Melanomaover 11 years ago
Mutation Tests in Melanoma Crucial for Treatmentover 11 years ago
What’s Next With Next-Generation BRAF Inhibitors?Advertisement
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
FDA Grants Traditional Approval to Pirtobrutinib in CLL/SLL
2
Durable Responses With Novel Cell Therapy TARA-002 in BCG-Naive NMIBC
3
JANX007 Shows Promising Efficacy, Safety in Phase 1 Trial Update
4
LP-184 Demonstrates Favorable Efficacy and Safety in Advanced Solid Tumors
5







































